These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 7910779)
1. Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies. Soares P; Sobrinho-Simöes M Cancer; 1994 Jun; 73(11):2879-81. PubMed ID: 7910779 [No Abstract] [Full Text] [Related]
2. Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies. Shimizu T; Usuda N; Yamanda T; Sugenoya A; Iida F Cancer; 1993 May; 71(9):2807-12. PubMed ID: 8096795 [TBL] [Abstract][Full Text] [Related]
3. [Proliferating cell nuclear antigen/cyclin (PCNA/Cyclin) in thyroid carcinoma]. Xu YJ Zhonghua Wai Ke Za Zhi; 1993 Oct; 31(10):628-9. PubMed ID: 7913437 [TBL] [Abstract][Full Text] [Related]
4. [Role of the MIB-1 proliferative markers in the diagnosis and prognosis of tumors of the thyroid gland]. Ludvíková M; Ryska A; Hovorková E; Pikner R Cesk Patol; 2002 Jan; 38(1):4-10. PubMed ID: 11933461 [TBL] [Abstract][Full Text] [Related]
5. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology. Maletta F; Massa F; Torregrossa L; Duregon E; Casadei GP; Basolo F; Tallini G; Volante M; Nikiforov YE; Papotti M Hum Pathol; 2016 Aug; 54():134-42. PubMed ID: 27085556 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid. Soares P; Cameselle-Teijeiro J; Sobrinho-Simões M Histopathology; 1994 Mar; 24(3):205-10. PubMed ID: 8200621 [TBL] [Abstract][Full Text] [Related]
7. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases. Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673 [TBL] [Abstract][Full Text] [Related]
8. Apoptosis and proliferative activity in thyroid tumors. Yoshida A; Nakamura Y; Imada T; Asaga T; Shimizu A; Harada M Surg Today; 1999; 29(3):204-8. PubMed ID: 10192728 [TBL] [Abstract][Full Text] [Related]
9. [HBME-1 immunostaining in thyroid pathology]. Rigau V; Martel B; Evrard C; Rousselot P; Galateau-Salle F Ann Pathol; 2001 Feb; 21(1):15-20. PubMed ID: 11223556 [TBL] [Abstract][Full Text] [Related]
10. Proliferative cell nuclear antigen expression in follicular tumours of the thyroid with special reference to oxyphilic cell lesions. Tateyama H; Yang YP; Eimoto T; Tada T; Inagaki H; Nakamura T; Iwase H; Kobayashi S Virchows Arch; 1994; 424(5):533-7. PubMed ID: 7913369 [TBL] [Abstract][Full Text] [Related]
11. Oncofetal expression of blood group-related antigen on morules in thyroid carcinoma. Okamoto Y; Yokoyama S; Sasaki A; Kashima K; Daa T; Nakayama I; Noguchi S Pathol Int; 1996 Nov; 46(11):867-73. PubMed ID: 8970196 [TBL] [Abstract][Full Text] [Related]
12. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634 [TBL] [Abstract][Full Text] [Related]
13. Proliferating cell nuclear antigen (PCNA) in medullary thyroid carcinoma. Skopelitou A; Korkolopoulou P; Papanikolaou A; Hadjiyannakis M J Cancer Res Clin Oncol; 1993; 119(7):379-81. PubMed ID: 8098331 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of dendritic/Langerhans cells in thyroid carcinomas. Yamakawa M; Yamada K; Orui H; Tsuge T; Ogata T; Dobashi M; Imai Y Anal Cell Pathol; 1995 Jun; 8(4):331-43. PubMed ID: 7577748 [TBL] [Abstract][Full Text] [Related]
15. Galectin-3 is a presurgical marker of human thyroid carcinoma. Orlandi F; Saggiorato E; Pivano G; Puligheddu B; Termine A; Cappia S; De Giuli P; Angeli A Cancer Res; 1998 Jul; 58(14):3015-20. PubMed ID: 9679965 [TBL] [Abstract][Full Text] [Related]
16. [Expression of E-cadherin in thyroid neoplastic tissues and its correlation with malignant and metastatic potential]. Naitoh A; Kobayashi S; Iwase H; Kuzushima T Nihon Rinsho; 1995 Jul; 53(7):1619-22. PubMed ID: 7629998 [TBL] [Abstract][Full Text] [Related]
17. S100A4 expression is an early event of papillary carcinoma of the thyroid. Ito Y; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A Oncology; 2004; 67(5-6):397-402. PubMed ID: 15713996 [TBL] [Abstract][Full Text] [Related]
18. [Clinicopathologic characteristics of thyroid-like follicular carcinoma of the kidney: an analysis of five cases and review of literature]. Chen X; Dou FX; Cheng XB; Guo AT; Shi HY Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):687-691. PubMed ID: 27760609 [No Abstract] [Full Text] [Related]
19. Immunohistochemical localization of acidic and basic fibroblast growth factors in human benign and malignant thyroid lesions. Kodama M; Daa T; Kashima K; Yokoyama S; Nakayama I; Noguchi S Jpn J Clin Oncol; 1994 Apr; 24(2):66-73. PubMed ID: 7512670 [TBL] [Abstract][Full Text] [Related]